Skip to content

Validation of Noninvasive Hemoglobin, Comparison of PVI to Standard Methods, and Validation of Clinical Efficacy of ORI

Validation of a Pulse Oximetry Based Hemoglobin Measurement System. Comparison of Plethysmographic Variability Index to Standard Methods of Guiding Fluid and Transfusion Management in the Critically Ill Adult Patients. Validation of Clinical Efficacy of ORI for Supplemental Oxygen Titration

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02841397
Enrollment
50
Registered
2016-07-22
Start date
2017-03-09
Completion date
2017-10-11
Last updated
2021-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Brief summary

The study goal is to establish the correlation of hemoglobin values determined by the noninvasive pulse oximetry-determined hemoglobin (SpHb) system with hemoglobin as measured by other validated devices. The study will also evaluation oxygen reserve index (ORI) to correlate with partial pressure of oxygen (PaO2), and to evaluate pleth variability index (PVI) with stroke volume variation (SVV) or pulse pressure variation (PPV) values.

Interventions

DEVICEMasimo Pulse CO-Oximeter

Noninvasive pulse oximeter with various features for measurement of hemoglobin, pleth variability index, and oxygen reserve index

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted into the ICU * Aged 18 years or older * Mechanically ventilated * Arterial line placed * Vigileo/Flotrac System being used for guidance of fluid management

Exclusion criteria

* Pregnancy * Prisoner status * Extreme hemodynamic instability * Multiple vasopressors in use with questionable peripheral blood flow * Lack of appropriate sites for sensor placement * Patient or patient's legal representative refusal

Design outcomes

Primary

MeasureTime frameDescription
Noninvasive Pulse Oximetry-determined SpHb BiasDuration of study participation is up to three days.Accuracy of SpHb will be determined by comparing it to the hemoglobin value obtained from a reference blood sample and calculating the accuracy root mean square (Arms) error value. In order to obtain the Arms value, the blood sample hemoglobin value is subtracted from SpHb value for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the Arms Error value.
Correlation of PVI Measurement Compared With PPV or SVVDuration of study participation is up to three days.Correlation of PVI measurement compared with pulse pressure variation PPV or stroke volume variation (SVV) measurement from arterial catheter
Correlation of ORI With Partial Pressure of Oxygen (PaO2) PaO2 Measurement From Blood Gas AnalysisDuration of study participation is up to three days.Concordance will be determined by comparing the trending ability of the Oxygen Reserve Index (ORI) measurement of the sensor with that of Partial Pressure of Oxygen in Blood (PaO2).

Countries

United States

Participant flow

Participants by arm

ArmCount
Test Group
All subjects will be enrolled into the test group and will receive Masimo Pulse CO-Oximeter for measurement of various physiological parameters. Masimo Pulse CO-Oximeter: Noninvasive pulse oximeter with various features for measurement of hemoglobin, pleth variability index, and oxygen reserve index
50
Total50

Baseline characteristics

CharacteristicTest Group
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
17 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
48 participants
Sex: Female, Male
Female
26 Participants
Sex: Female, Male
Male
22 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 50
other
Total, other adverse events
0 / 50
serious
Total, serious adverse events
0 / 50

Outcome results

Primary

Correlation of ORI With Partial Pressure of Oxygen (PaO2) PaO2 Measurement From Blood Gas Analysis

Concordance will be determined by comparing the trending ability of the Oxygen Reserve Index (ORI) measurement of the sensor with that of Partial Pressure of Oxygen in Blood (PaO2).

Time frame: Duration of study participation is up to three days.

Population: Data from 8 subjects were obtained. At least two samples per subject are required to compare ORI trending ability; however, only 1 sample was obtained from each subject which precluded conduct of any data analysis.

Primary

Correlation of PVI Measurement Compared With PPV or SVV

Correlation of PVI measurement compared with pulse pressure variation PPV or stroke volume variation (SVV) measurement from arterial catheter

Time frame: Duration of study participation is up to three days.

Population: There was no reference SVV or PPV data available for PVI data analysis.

Primary

Noninvasive Pulse Oximetry-determined SpHb Bias

Accuracy of SpHb will be determined by comparing it to the hemoglobin value obtained from a reference blood sample and calculating the accuracy root mean square (Arms) error value. In order to obtain the Arms value, the blood sample hemoglobin value is subtracted from SpHb value for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the Arms Error value.

Time frame: Duration of study participation is up to three days.

Population: A total of 12 subjects were excluded from data analysis Subjects were excluded from data analysis for different reasons. Reason 1: Blood sample could not be analyzed because received out of analyzer required time window Reason 2: Sensor data is not available Reason 3: No time matched sensor and blood sample data pair for analysis Reason 4: Reference tHb error. tHb difference \>1g/dL between different methods

ArmMeasureValue (NUMBER)
Test GroupNoninvasive Pulse Oximetry-determined SpHb Bias0.9 g/dL

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026